Chinese Antibody Society Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2017 | 132,743 | 90,127 | 42,616 | 5.7 | — |
| 2018 | 285,096 | 148,167 | 136,929 | 14.5 | 0% |
| 2019 | 254,697 | 243,329 | 11,368 | 9.4 | 0% |
| 2020 | 128,477 | 124,107 | 4,370 | 18.9 | 0% |
| 2021 | 92,029 | 38,479 | 53,550 | 77.6 | 0% |
| 2022 | 150,987 | 55,675 | 95,312 | 74.2 | 0% |
| 2023 | 405,212 | 355,081 | 50,131 | 13.3 | 0% |
In its most recent public year (2023), this organization brought in $50,131 more than it spent. Its reserves stood at about 13.3 months of spending, up from 5.7 in 2017. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Chinese Antibody Society Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works